Evidence map›Paper›PMID 34934895›Full record

ArticleResearch and practice in thrombosis and haemostasis2021

Thrombo-inflammatory biomarkers and D-dimer in a biracial cohort study.

Debora Kamin Mukaz, Mansour Gergi, Insu Koh, Neil A Zakai, Suzanne E Judd, Michelle Sholzberg, Lisa Baumann Kreuziger, Kalev Freeman, Christos Colovos, Nels C Olson and 1 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Research and practice in thrombosis and haemostasis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04505774 (A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic and Additional Strategies in Hospitalized Adults With COVID-19), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04505774 phase4completednot on this map

A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic and Additional Strategies in Hospitalized Adults With COVID-19

TypeinterventionalSponsorMatthew Neal MDRan2020 to 2024Enrolled3,591ConditionsCovid19Armstheraputic heparin, prophylactic heparin, P2Y12, Crizanlizumab Injection, SGLT2 inhibitor
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Observational
  2. Early prediction of plastic bronchitis in pediatric patients withFrontiers in cellular and infection microbiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Thrombo-inflammatory biomarkers and D-dimer in a biracial cohort study.Research and practice in thrombosis and haemostasis · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Debora Kamin MukazDepartment of Medicine Larner College of Medicine at the University of Vermont Burlington Vermont USA.ORCID https://orcid.org/0000-0001-5573-2573
Mansour GergiDepartment of Medicine Larner College of Medicine at the University of Vermont Burlington Vermont USA.
Insu KohDepartment of Pathology and Laboratory Medicine Larner College of Medicine at the University of Vermont Burlington Vermont USA.
Neil A ZakaiDepartment of Medicine Larner College of Medicine at the University of Vermont Burlington Vermont USA.
Suzanne E JuddDepartment of Biostatistics University of Alabama at Birmingham Birmingham Alabama USA.
Michelle SholzbergDepartment of Medicine University of Toronto Toronto Ontario Canada.ORCID https://orcid.org/0000-0003-1220-0301
Lisa Baumann KreuzigerBlood Research Institute Versiti, Milwaukee Wisconsin USA.ORCID https://orcid.org/0000-0002-1171-0548
Kalev FreemanDepartment of Surgery Larner College of Medicine at the University of Vermont Burlington Vermont USA.ORCID https://orcid.org/0000-0003-4817-2955
Christos ColovosDepartment of Surgery Larner College of Medicine at the University of Vermont Burlington Vermont USA.
Nels C OlsonDepartment of Pathology and Laboratory Medicine Larner College of Medicine at the University of Vermont Burlington Vermont USA.ORCID https://orcid.org/0000-0003-1192-9969
Mary CushmanDepartment of Medicine Larner College of Medicine at the University of Vermont Burlington Vermont USA.ORCID https://orcid.org/0000-0002-7871-6143
University of Vermont · USMedical College of Wisconsin · USSt. Michael's Hospital · CAUniversity of Alabama at Birmingham · US

Funding

VCID and Stroke in a Bi-racial National CohortU01NS041588 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CUSHMAN, MARY, HOWARD, GEORGE · 2002 to 2022
$96.0M
Regional & Racial Differences in Hemostasis & Risk of Stroke & Heart DiseaseK08HL096841 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI ZAKAI, NEIL ADRIAN · 2010 to 2014
$705k
NHLBI NIH HHS K08 HL096841NINDS NIH HHS U01 NS041588
6 · The paper itself

Abstract

backgroundHigher D-dimer is a risk factor for cardiovascular diseases and venous thromboembolism. In the general population, D-dimer and other thrombo-inflammatory biomarkers are higher among Black individuals, who also have higher risk of these conditions compared to White people.

objectiveTo assess whether Black individuals have an exaggerated correlation between D-dimer and thrombo-inflammatory biomarkers characteristic of cardiovascular diseases.

methodsLinear regression was used to assess correlations of 11 thrombo-inflammatory biomarkers with D-dimer in a cross-sectional study of 1068 participants of the biracial Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort.

resultsAdverse levels of most biomarkers, especially fibrinogen, factor VIII, C-reactive protein, N-terminal pro-B-type natriuretic peptide, and interleukin (IL)-6, were associated with higher D-dimer. Several associations with D-dimer differed significantly by race. For example, the association of factor VIII with D-dimer was more than twice as large in Black compared to White participants. Specifically, D-dimer was 26% higher per standard deviation (SD) higher factor VIII in Black adults and was only 11% higher per SD higher factor VIII in White adults. In Black but not White adults, higher IL-10 and soluble CD14 were associated with higher D-dimer.

conclusionsFindings suggest that D-dimer might relate to Black/White differences in cardiovascular diseases and venous thromboembolism because it is a marker of amplified thrombo-inflammatory response in Black people. Better understanding of contributors to higher D-dimer in the general population is needed.

Indexed as

biomarkerscardiovascular diseasesD‐dimerracethrombo‐inflammation

Identifiers

PMID34934895
PMCPMC8652130
OpenAlexW4200046503

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.